Evercore ISI Group Downgrades Charles River to In-Line, Lowers Price Target to $190
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has downgraded Charles River Laboratories (NYSE:CRL) from Outperform to In-Line and reduced the price target from $225 to $190.
October 07, 2024 | 11:41 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Evercore ISI Group has downgraded Charles River Laboratories from Outperform to In-Line, reducing the price target from $225 to $190. This suggests a less optimistic outlook on the stock's performance.
The downgrade from Outperform to In-Line by a reputable analyst group like Evercore ISI suggests a less favorable view on Charles River's future performance. The reduction in price target from $225 to $190 indicates a significant decrease in expected stock value, likely leading to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100